USPTO trademark

VUPREMSI

RegisteredUSPTOWord markClass 5

"VUPREMSI" is a word mark owned by Glaxo Group Limited, filed at the USPTO on April 10, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolio Get this data via the API

Data current as of November 25, 2025Official USPTO record

As filed with the USPTO

Status: Registered; Since November 25, 2025
Filed: April 10, 2025
Registered: November 25, 2025
Priority date: February 7, 2025; Claimed from United Kingdom
Application no.: 99130082
Registration no.: 8040884
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns VUPREMSI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Christopher M. Hanes

GSK

Goods and services

What the mark covers

The products and services VUPREMSI is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

November 25, 2025Notice of registration confirmation emailed
November 25, 2025Registered-principal register
October 7, 2025Official gazette publication confirmation e-mailed
October 7, 2025Published for opposition
October 1, 2025Notification of notice of publication e-mailed
September 9, 2025Approved for pub - principal register
September 4, 2025Assigned to examiner
July 24, 2025Teas amendment entered before attorney assigned
July 24, 2025Teas voluntary amendment received
April 10, 2025Application filing receipt mailed

2 earlier steps on the official record.

FAQ

About VUPREMSI

Who owns the trademark "VUPREMSI"?

The USPTO trademark "VUPREMSI" (application 99130082) is owned by Glaxo Group Limited.

What is the status of "VUPREMSI"?

Its status at the USPTO is: registered.

When was "VUPREMSI" registered?

It was registered on November 25, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull VUPREMSI and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2aa9-68f3-708b-939c-5a3320a641eb
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2aa9-68f3-708b-939c-5a3320a641eb",
  "object": "trademark",
  "mark_text": "VUPREMSI",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99130082",
  "filing_date": "2025-04-10",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}